Agaricus Blazei

No. Agaricus does not treat, cure or prevent cancer or any other disease, and no regulator anywhere permits that claim. What is true is that it became one of the most popular alternative products among Japanese cancer patients - and that popularity is how we learned about its risks, not its benefits. Memorial Sloan Kettering's assessment is that studies in humans are limited and larger studies are needed to resolve the ambiguity, and that liver damage and deaths have been reported following consumption. Wikipedia's summary of the evidence base notes that Agaricus mushrooms have not been assessed by sufficient high-quality clinical research to define safety and biological properties, and that the US FDA has issued warning letters to companies marketing Agaricus products with unproven disease claims. If you are living with cancer, do not take Agaricus without your oncology team's explicit agreement. MSK About Herbs: Agaricus ↗

The fresh mushroom is edible and pleasant. A concentrated extract is a different proposition, and this is the one place we will not soften the message. In 2006, Mukai and colleagues reported in the Japanese Journal of Clinical Oncology on three advanced cancer patients who developed severe hepatic damage while taking Agaricus blazei extract; two died of fulminant hepatitis. In one patient liver function recovered after stopping and worsened again on restarting. Memorial Sloan Kettering lists abnormal liver function among the side effects and notes reported hepatic dysfunction and deaths. Contact cheilitis - inflamed lips - has also been reported. Causation is not proven and other studies found no hepatic toxicity, but a signal this severe deserves respect rather than reassurance. Avoid it if you have any liver condition, and stop and get medical advice if you notice nausea, unusual fatigue, dark urine or yellowing of the eyes or skin. Mukai et al. 2006, Jpn J Clin Oncol ↗

It isn't. The species was first described scientifically by Charles Horton Peck in 1893 and grown as a table vegetable in the eastern United States around the turn of the twentieth century. It was rediscovered in Brazil near Piedade, Sao Paulo state, misidentified as Agaricus blazei, and sent to Japan in the mid-1960s to be studied for medicinal properties - which is when the marketing names arrived: cogumelo do sol, mushroom of God, mushroom of life, himematsutake. Every part of the 'medicinal' story is twentieth-century and commercial. Tellingly, Health Canada's mushrooms monograph grants Agaricus blazei no traditional-medicine claim at all, while granting Reishi, Turkey Tail, Shiitake and Maitake permitted Traditional Chinese Medicine or Herbal Medicine wording in the same document. It is a modern supplement with a good origin story, not an ancient remedy. Agaricus subrufescens (taxonomy and history), Wikipedia ↗

Two problems with this. First, the ranking is wrong: independent screening of commercially cultivated and wild mushrooms has repeatedly placed Turkey Tail at the top for beta-glucan content, above Agaricus. What genuinely distinguishes Agaricus is the proportion of (1-6)-linked beta-glucan it carries, not the raw total. Second, and more importantly, potency is not the same as effect. A higher standardised percentage tells you the extract is more concentrated and better characterised - which is a real quality advantage, and it is why we publish our 40% figure. It does not tell you that more happens in your body, because no trial has ever shown a dose-response relationship between beta-glucan percentage and any human outcome for this mushroom. Use the number to judge the product, not to predict the result. Health Canada NHPID mushrooms monograph ↗

It's a misapplied name, and everyone in the field knows it. The Brazilian mushroom was mistaken for Agaricus blazei Murrill, a different species described from Florida, and the wrong name stuck across decades of commerce and published research. In 2002 Didukh and Wasser correctly rejected 'blazei' but proposed Agaricus brasiliensis, a name already taken by a different fungus described in 1830. Richard Kerrigan then used genetic and interfertility testing (Mycologia, 2005) to show the Brazilian strains were the same species as North American Agaricus subrufescens - and because subrufescens is the oldest valid name, it takes priority. MycoBank and Index Fungorum now list A. subrufescens as accepted, with blazei, brasiliensis and rufotegulis as synonyms. We still print 'Agaricus blazei' because that is what Health Canada's monograph and every supplement label uses, and because you would not find the product otherwise. But subrufescens is the correct answer. Kerrigan 2005, Mycologia (via Agaricus subrufescens, Wikipedia) ↗

It's a tan-capped, almond-scented mushroom whose correct scientific name is Agaricus subrufescens - first described by Charles Horton Peck in 1893 and grown as food in the eastern United States around 1900. When it was found again in Brazil it was misidentified as Agaricus blazei Murrill, a different Florida species, and that wrong name stuck across decades of commerce and research. Genetic and interfertility testing published by Richard Kerrigan in Mycologia in 2005 settled it: the Brazilian strains are Agaricus subrufescens, which as the oldest name takes priority. Along the way it picked up an unusual number of marketing names - cogumelo do sol (mushroom of the sun), cogumelo de Deus, ABM, royal sun agaricus, almond mushroom, and in Japan himematsutake, 'princess matsutake.' We label it Agaricus Blazei because that's the name Health Canada's monograph and every supplement label uses.

Two things, and only two. Health Canada's compendial mushrooms monograph permits Agaricus blazei as a 'source of antioxidants' (including the longer wording about helping protect against the oxidative damage caused by free radicals) and as a 'source of fungal polysaccharides with immunomodulating properties.' That's the complete list. There's no permitted energy claim, no cognition claim, no liver claim, no traditional-medicine claim of any kind - which is notable, because in the same document Reishi, Turkey Tail, Shiitake and Maitake all get traditional or herbal-medicine wording. The monograph also lists Agaricus only as an aqueous extract preparation, sets the ceiling at 9 g/day of dried mushroom equivalent (and up to 40% polysaccharides if standardized), restricts it to adults 18 and over, and requires two warnings: consult a practitioner if pregnant or breastfeeding, and consult a practitioner if you have diabetes.

Follow the label on whatever product you're holding, because concentrated extracts and dried powders are not interchangeable. For context: Health Canada permits up to 9 g per day of dried Agaricus blazei mushroom equivalent, prepared as an aqueous extract, for adults 18 and over - that's a ceiling, not a target. The best-designed human trial we have (Hsu and colleagues, 2007) used 1,500 mg per day of extract for 12 weeks in people with type 2 diabetes, and the AndoSan studies in inflammatory bowel disease used a standardised liquid extract daily over several weeks. A practical starting point with a concentrated extract is around half to one teaspoon in a warm drink, once a day. Take it with food. And be aware that Health Canada attaches its diabetes warning to any product providing 300 mg or more of dried Agaricus per day as an aqueous extract - so that threshold is low, and the caution applies at ordinary doses.

This is the most important question on the page, so here's the unvarnished answer. There are documented case reports of severe liver injury associated with Agaricus blazei extract. The best known is Mukai and colleagues (Japanese Journal of Clinical Oncology, 2006), describing three advanced cancer patients who developed severe hepatic damage while taking the extract; two died of fulminant hepatitis, and in one the liver recovered after stopping and worsened again on restarting. Memorial Sloan Kettering lists abnormal liver function among Agaricus's side effects and notes reported hepatic dysfunction and deaths. Confusingly, the evidence isn't all one way - a small study reported that an Agaricus extract normalised liver enzymes in chronic hepatitis B patients, rodent studies suggest protection against chemical liver injury, and many clinical studies reported no hepatic toxicity. Case reports can't prove causation, and these patients were seriously ill and on other treatments. But the asymmetry matters: the downside is catastrophic and the upside is speculative. Don't take Agaricus if you have liver disease, raised liver enzymes or a history of drug-induced liver injury, don't take it during cancer treatment without your oncology team's agreement, and stop immediately if you develop nausea, unusual tiredness, dark urine or yellowing of the skin or eyes.

It means that in every gram of our extract, 400 mg is verified beta-glucan - the fungal cell-wall polysaccharide that all the research revolves around. It matters because the alternative measure, 'polysaccharides', can legally include starch carried over from the grain a mycelium was grown on, which pads the number without adding anything active. Beta-glucan can't be faked that way, which is why fewer brands publish it. Health Canada's monograph caps standardized aqueous extracts of Agaricus at 40% polysaccharides alongside the 9 g/day crude-equivalent limit, so 40% sits right at the top of the specification Canadian regulators recognise for this species. Is higher always better? Higher is more concentrated and more verifiable - genuinely useful for judging a product. But no human trial has ever demonstrated that a higher beta-glucan percentage produces a bigger effect in a person. Use the number to compare products, not to predict outcomes.

Anyone with a liver condition, elevated liver enzymes or a history of drug-induced liver injury - that's the firmest one, for the reasons set out in the liver question above. Anyone pregnant or breastfeeding: Health Canada requires a practitioner-consultation warning and the safety data simply isn't there. Anyone with diabetes or taking glucose-lowering medication, without speaking to their prescriber first - Health Canada mandates that warning for any product providing 300 mg or more of dried Agaricus per day as an aqueous extract, and the one good randomised trial in this area was specifically an add-on to metformin and gliclazide. Anyone under 18, since the monograph covers adults only. Anyone with a mushroom allergy - contact cheilitis, inflammation of the lips, has been reported with Agaricus extract. And anyone in active cancer treatment, without their oncology team's explicit agreement: that's the population the liver case reports came from, and Memorial Sloan Kettering also notes in-vitro inhibition of CYP3A4, an enzyme that clears many medications, with clinical relevance still unknown.

Honestly? You may not notice anything, and that's a normal outcome for this ingredient. Agaricus contains no stimulant and nothing about the proposed beta-glucan mechanism suggests a same-day sensation. The human trials that reported changes ran for weeks to months - the diabetes trial was 12 weeks, the inflammatory bowel disease studies several weeks - and they measured blood markers and questionnaire scores rather than anything a person would spontaneously feel. If you're taking it, treat it as quiet background support within a broader routine, give it a couple of months of consistent daily use before forming a view, and be suspicious of any product or review promising you'll feel a difference this week.

It's one of the nicer functional mushrooms to drink. It's called the almond mushroom for a reason - the flesh is sweet with a distinct almond aroma, which comes from benzaldehyde, benzyl alcohol, benzonitrile and methyl benzoate. Stir half to one teaspoon of extract into a warm drink, a smoothie or a broth; it works well in anything with a nutty or vanilla note and doesn't need masking the way earthier mushrooms do. Take it with food, once a day, and keep it consistent rather than heavy. One thing to note: Health Canada's monograph lists Agaricus blazei only as an aqueous extract preparation, so unlike some mushrooms in the same document there's no listed route for plain dried, unextracted powder - if you see a product selling raw Agaricus powder, that's worth a question.